Key result
Extra-pulmonary vein triggers linked to ~91% higher AF recurrence after de novo ablation.
Why the study?
Extra-pulmonary vein triggers can play a significant role in AF recurrence after catheter ablation, prompting exploration of their characteristics in de novo and repeat procedures.
Does the presence of extra-pulmonary vein triggers increase atrial fibrillation recurrence in patients undergoing de novo or repeat catheter ablation?
Cohort (n=2,118)
No
Does the presence of extra-pulmonary vein triggers increase atrial fibrillation recurrence in patients undergoing de novo or repeat catheter ablation?
Effect estimate: HR 1.91 (95% CI 1.54-2.38)
Absolute Event Rate: 44.9% vs 31.6%
p-value: p=<0.001
Extra-pulmonary vein triggers are common in AF patients with significant remodeling and are independently associated with poorer rhythm outcomes after de novo and repeat catheter ablation.
May inform post-ablation risk stratification; leaves open whether targeting extra-PV triggers improves outcomes in trials.
Background: Extra-pulmonary vein triggers can play a significant role in atrial fibrillation recurrence after catheter ablation. We explored the characteristics of the extra-pulmonary vein (PV) triggers in de novo and repeat atrial fibrillation (AF) catheter ablation (AFCA). Methods: We included 2,118 patients who underwent a de novo AFCA (women 27.6%, 59.2 ± 10.9 years old, paroxysmal AF 65.9%) and 227 of them conducted repeat procedures. All included patients underwent isoproterenol provocation tests at the end of the procedure, and then we analyzed extra-PV triggers-related factors. Results: Extra-PV triggers were documented in 11.7% of patients undergoing de novo AFCA (1.22 ± 0.46 foci per patient) and 28.6% undergoing repeat AFCA (1.49 ± 0.73 foci per patient). Older age and higher LA volume index in de novo procedures and women, diabetes, and higher parasympathetic nerve activity (heart rate variability) in repeat-AFCA were independently associated with the existence of extra-PV triggers. The septum (19.9%), coronary sinus (14.7%), and superior vena cava (11.2%) were common extra-PV foci. Among 46 patients who were newly found to have mappable extra-PV triggers upon repeat procedures, 15 (32.6%) matched with the previous focal or empirical extra-PV ablation sites. The rate of AF recurrence was significantly higher in patients with extra-PV triggers than in those without after de novo (HR 1.91, 95% CI 1.54–2.38, p < 0.001) and repeat procedures (HR 2.68, 95% CI 1.63–4.42, p < 0.001). Conclusions: Extra-PV triggers were commonly found in AF patients with significant remodeling and previous empirical extra-PV ablation. The existence of extra-PV triggers was independently associated with poorer rhythm outcomes after the de novo and repeat AFCA.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2021) conducted a cohort in Atrial fibrillation (n=2,118). Presence of extra-pulmonary vein triggers vs. Absence of extra-pulmonary vein triggers was evaluated on Clinical recurrence of atrial fibrillation after de novo ablation (HR 1.91, 95% CI 1.54-2.38, p=<0.001). The presence of extra-pulmonary vein triggers was independently associated with a higher rate of clinical atrial fibrillation recurrence after de novo catheter ablation (HR 1.91).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: